Patents by Inventor Malar Pannirselvam

Malar Pannirselvam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Certain 1H-Imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-Imidazo[4,5-b]pyrazin-2-ols and Methods for Their Use
    Publication number: 20140303366
    Abstract: Provided is a method of treating myasthenia gravis in a patient by administering to the patient an effective amount of a skeletal muscle troponin activator, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 7, 2014
    Publication date: October 9, 2014
    Inventors: Aaron Hinken, Fady Malik, Malar Pannirselvam, Alan Russell
  • Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
    Patent number: 8716291
    Abstract: Provided are compounds of Formula I and compounds of Formula II: and pharmaceutically acceptable salts thereof, and methods for their use.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: May 6, 2014
    Assignee: Cytokinetics, Inc.
    Inventors: Aaron Hinken, Fady Malik, Malar Pannirselvam, Alan Russell
  • CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
    Publication number: 20130053389
    Abstract: Provided is a method of treating myasthenia gravis in a patient by administering to the patient an effective amount of a skeletal muscle troponin activator, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 12, 2012
    Publication date: February 28, 2013
    Inventors: Aaron Hinken, Fady Malik, Malar Pannirselvam, Alan Russell
  • Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
    Patent number: 8299248
    Abstract: Provided are methods for treating myasthenia gravis in a patient, comprising administering to the patient an effective amount of at least one chemical entity chosen from compounds of Formula I and compounds of Formula II: and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: May 14, 2010
    Date of Patent: October 30, 2012
    Assignee: Cytokinetics, Incorporated
    Inventors: Aaron Hinken, Fady Malik, Malar Pannirselvam, Alan Russell
  • Certain Chemical Entities, Compositions and Methods
    Publication number: 20110014212
    Abstract: Provided is a method of treating myasthenia gravis in a patient by administering to the patient an effective amount of a skeletal muscle troponin activator, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 14, 2010
    Publication date: January 20, 2011
    Inventors: Aaron Hinken, Fady Malik, Malar Pannirselvam, Alan Russell